MacroGenics saw the highest growth of 299% in patent filings and 99% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 299% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of MacroGenics’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

MacroGenics has been focused on protecting inventions in United States(US) with six publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 27% filings and 60% grants. The United States(US), European Patent Office(EPO), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where MacroGenics is filings its patents. Among the top granted patent authorities, MacroGenics has 60% of its grants in United States(US) and 40% in Israel(IL).

Regeneron Pharmaceuticals and Amgen could be the strongest competitors for MacroGenics

In terms of grant share, MacroGenics stands in eighth position among its competitors. Regeneron Pharmaceuticals and Amgen secured the top positions according to recent patent publication data.

Patents related to rare diseases and immuno-oncology lead MacroGenics's portfolio

MacroGenics has the highest number of patents in rare diseases followed by, immuno-oncology. For rare diseases, nearly 75% of patents were filed and 100% of patents were granted in Q1 2024.

Breast cancer related patents lead MacroGenics portfolio followed by ovarian cancer, and prostate cancer

MacroGenics has highest number of patents in breast cancer followed by ovarian cancer, prostate cancer, bladder carcinoma, and melanoma. For breast cancer, nearly 3% of patents were filed and 1% of patents were granted in Q1 2024.

For comprehensive analysis of MacroGenics's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.